Dongliang Lin Net Worth & Insider Trades

Dongliang Lin Casi Pharmaceuticals, Inc

As of November 14, 2018

What is Dongliang Lin's Net Worth?

The current estimated net worth of Casi Pharmaceuticals, Inc's Dongliang Lin is estimated to be about $33.04M . Dongliang Lin owns about 8,498,765 units of Casi Pharmaceuticals, Inc common stock. In the last 2 years at Casi Pharmaceuticals, Inc, Dongliang Lin has sold an estimated value of $0 worth.

What is Dongliang Lin's Past Insider Trading?

Dongliang Lin's largest purchase order was 3,753,855 units , worth over $4.47M on June 29, 2016. In total, Dongliang Lin has made about 2 transactions over 2 years of their time at Casi Pharmaceuticals, Inc. Dongliang Lin usually trades in June and November, with the busiest year in 2018 and 2016.

SPARKLE BYTE LTD, SNOW MOON LTD, PARTNERSHIP LIMITED CENTER MANAGEMENT JINGRAN TIANJIN, HE XIE AI QI INVESTMENT MANAGEMENT BEIJING CO LTD, Jianguang Li, Dongliang Lin, Fei Yang, Hugo Shong

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Dongliang Lin's' Mailing Address?

  • Mailing address is 6/f, Tower A, Cofco Plaza 8 Jianguomennei Avenue Beijing F4 100005 China

Casi Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Wei-Wu He, Ph.D. 2020 $577,656 - - - - $241,831 $819,487
Wei-Wu He, Ph.D. 2019 $423,848 - - $8,600,000 - $241,555 $9,265,103
Wei (Larry) Zhang 2020 $437,094 - - - - $278,675 $715,769
Wei (Larry) Zhang 2019 $339,207 - - $450,000 - $166,889 $985,186
Alexander Zukiwski, MD 2020 $414,529 - - - - $28,250 $442,779
Alexander Zukiwski, MD 2019 $407,600 $100,000 - $426,000 - $27,750 $961,350
Weihao Xu 2020 $14,583 - - $1,440,000 - - $1,454,583
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/895051/000110465921063604/tm2114348d2_def14a.htm

What are Casi Pharmaceuticals, Inc's Past Insider Trades?

Casi Pharmaceuticals, Inc's most recent insider trade came on September 8, 2022 by James Huang who bought 55,573 units worth $229.66K . In the last 6 years, insiders at Casi Pharmaceuticals, Inc have sold an estimated value of $5.53M and bought an estimated value of $56.36M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Wei-Wu He, Chairman and CEO,  James Huang, Director,  and Cynthia W Hu, COO .

CASI Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...